Functional Genomics and Disease
2003,
Prague, Czech Republic
photos:
opening |
ESF dinner | Day 3 |
Day 4 | Brewery
Party
Our
first major biennial conference, Functional Genomics and
Disease 2003, was held at the Hilton Hotel in Prague, May
14-17th 2003. The theme of the conference was chosen to
illustrate the growing importance of functional genomics
research for understanding disease mechanisms and development
of new therapies. A local organising committee was chaired
by Vaclav Paces (Institute of Molecular Genetics, Prague)
and an International Programme Committee was chaired by
Mike Taussig (Babraham Institute, Cambridge). Altogether,
the conference invited 77 distinguished speakers and chairpersons
and was attended by a further 500 delegates who presented
over 300 posters.
The
opening ceremony was addressed by ESF Secretary General
Enric Banda, the Mayor of the city of Prague Pavel Bern,
the Deputy Minister of Education Petr Kolar, and the ESF
representative for the Czech Republic Josef Syka, as well
as by Vaclav Paces and Mike Taussig. Other members of the
ESF governing council and the LESC and EMRC committees attended.
The EC was represented by Manuel Hallen, Head of Fundamental
Genomics at the Directorate for Health Research, who also
gave a talk later on the 6th Framework Programme. Plenary
lectures at the opening were given by Leena Peltonen (Helsinki)
and Hans Lehrach (Berlin). The Prague Castle band provided
musical entertainment before a welcome reception.
The
conference layout comprised plenary sessions, parallel morning
symposia on specific disease areas and parallel afternoon
workshops on functional genomics technologies. In addition
to those mentioned, the plenary speakers were Ian Dunham
(Hinxton), Mathias Uhlen (Stockholm), Jurg Ott (New York),
Kelly Frazer (Mountain View), Klaus Lindpaintner (Basel),
Jan van Oostrum (Basel) and Georg Feger (Geneva). The symposium
topics covered a wide range and included Infection and Host/Parasite
Interaction, Hereditary Disease, Oncology, Mitochondrial
Diseases, Complex Diseases, Neurological Disease, and Pharmacogenomics
and Drug Discovery. The workshop topics reflecting high
throughput technologies were Model Systems and Knockout,
Transcriptome, Proteome and Protein-protein Interactions,
Bioinformatics, Cell and Gene Therapy, and Advances in Microarrays.
In addition there was a session on Biobanking, Intellectual
Property and Ethics, and a half-day workshop on Environmental
Genomics organised by Victor de Lorenzo (Madrid). A pre-conference
symposium was held by Waters and a number of companies held
lunchtime information sessions (Applied Biosystems, Invitrogen,
Affymetrix, LION Bioscience and IBM, Beckman Coulter and
Thermo Electron Corporation).
In
addition to funding from the ESF functional genomics programme,
the conference received generous sponsorship from Roche
Diagnostics, Invitrogen, Novartis and Serono and further
funds were raised from the associated commercial exhibition
in which 23 companies participated. These sources helped
to subsidise the registration fee and keep it at a very
reasonable level, with special rates for young researchers.
The event was managed by a local conference organising company,
Czech-In. The ESF programme provided 50 bursaries for young
researchers selected on quality of posters. The main social
event was an evening party at the Staropramen Brewery in
Prague and there was a post-conference excursion to the
exhibition on 'Mendel: The Genius of Genetics' at Mendel's
Abbey near Brno.
The
conference was a major event which brought the ESF functional
genomics programme to the attention of a wide, international
audience. Comments during and after were extremely positive
and enthusiastic, with many pleasing remarks on the excellence
of the presentations. It was deemed a high profile success
at all levels, from organisation to science, and many attendees
expressed the hope that we would organise a similar event.
The current intention is to do so in 2005.